发明授权
US07253263B1 Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3
失效
针对神经节苷脂GD3的互补决定区移植抗体及抗神经节苷脂GD3的抗体衍生物
- 专利标题： Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3
- 专利标题（中）： 针对神经节苷脂GD3的互补决定区移植抗体及抗神经节苷脂GD3的抗体衍生物
-
申请号： US10089500申请日： 2000-09-29
-
公开(公告)号： US07253263B1公开(公告)日： 2007-08-07
- 发明人: Nobuo Hanai , Kenya Shitara , Kazuyasu Nakamura , Rinpel Niwa
- 申请人： Nobuo Hanai , Kenya Shitara , Kazuyasu Nakamura , Rinpel Niwa
- 申请人地址： JP Tokyo
- 专利权人： Kyowa Hakko Kogyo Co., Ltd.
- 当前专利权人： Kyowa Hakko Kogyo Co., Ltd.
- 当前专利权人地址： JP Tokyo
- 代理机构： Nixon & Vanderhye P.C.
- 优先权： JP11-278291 19990930; JP2000-105088 20000406
- 国际申请： PCT/JP00/06774 WO 20000929
- 国际公布： WO01/23432 WO 20010405
- 主分类号： C12P21/08
- IPC分类号： C12P21/08 ; C07K16/00 ; C12N5/06 ; C12P21/04 ; A61K39/395 ; C07H21/04
摘要：
The present invention relates to a human CDR-grafted antibody against ganlioside GD3 (hereinafter referred to “GD3”), derivatives of an anti-GD3 antibody and cytokine, and use for treatment and diagnosis of the antibody and the derivatives.
信息查询
